APO Research

APO RESEARCH · REPORT

Rhizoma Gastrodiae Tablets

Selected research

Market Analysis & Forecast

Global Rhizoma Gastrodiae Tablets Market Analysis and Forecast 2026-2032

Market perspective

The global Rhizoma Gastrodiae Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Rhizoma Gastrodiae Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Rhizoma Gastrodiae Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Rhizoma Gastrodiae Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Rhizoma Gastrodiae Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Rhizoma Gastrodiae Tablets include Zhaotong Huacheng Pharmaceutical, Taiji Group Sichuan Mianyang Pharmaceutical, Shaanxi Tianyang Pharmaceutical, Tsumura & Co., Lanzhou Foci Pharmaceutical, Guizhou Bailing, Guangxi Chanfang Pharmaceutical, Guangdong Luofushan National Pharmaceutical and Tongrentang Chinese Medicine, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Rhizoma Gastrodiae Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Rhizoma Gastrodiae Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Rhizoma Gastrodiae Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Rhizoma Gastrodiae Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Rhizoma Gastrodiae Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Rhizoma Gastrodiae Tablets sales, projected growth trends, production technology, application and end-user industry.

Rhizoma Gastrodiae Tablets Segment by Company

Zhaotong Huacheng Pharmaceutical

Taiji Group Sichuan Mianyang Pharmaceutical

Shaanxi Tianyang Pharmaceutical

Tsumura & Co.

Lanzhou Foci Pharmaceutical

Guizhou Bailing

Guangxi Chanfang Pharmaceutical

Guangdong Luofushan National Pharmaceutical

Tongrentang Chinese Medicine

Rhizoma Gastrodiae Tablets Segment by Type

Gastrodia elata f.glauca

G.elata.BI.f elata

Other

Rhizoma Gastrodiae Tablets Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Rhizoma Gastrodiae Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rhizoma Gastrodiae Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rhizoma Gastrodiae Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rhizoma Gastrodiae Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Rhizoma Gastrodiae Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Rhizoma Gastrodiae Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rhizoma Gastrodiae Tablets sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Rhizoma Gastrodiae Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Gastrodia elata f.glauca Major Manufacturers Table 3. G.elata.BI.f elata Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Rhizoma Gastrodiae Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Pharmacies Major Manufacturers Table 7. Online Pharmacies Major Manufacturers Table 8. Retail Pharmacies Major Manufacturers Table 9. Rhizoma Gastrodiae Tablets Industry Trends Table 10. Rhizoma Gastrodiae Tablets Industry Drivers Table 11. Rhizoma Gastrodiae Tablets Industry Opportunities and Challenges Table 12. Rhizoma Gastrodiae Tablets Industry Restraints Table 13. Global Rhizoma Gastrodiae Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Rhizoma Gastrodiae Tablets Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Rhizoma Gastrodiae Tablets Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Region (2021-2026) Table 17. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Region (2027-2032) Table 18. Global Rhizoma Gastrodiae Tablets Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Rhizoma Gastrodiae Tablets Sales by Region (2021-2026) & (k units) Table 20. Global Rhizoma Gastrodiae Tablets Sales by Region (2027-2032) & (k units) Table 21. Global Rhizoma Gastrodiae Tablets Sales Market Share by Region (2021-2026) Table 22. Global Rhizoma Gastrodiae Tablets Sales Market Share by Region (2027-2032) Table 23. Global Rhizoma Gastrodiae Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Rhizoma Gastrodiae Tablets Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Rhizoma Gastrodiae Tablets Sales Market Share by Manufacturers (2021-2026) Table 27. Global Rhizoma Gastrodiae Tablets Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Rhizoma Gastrodiae Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Rhizoma Gastrodiae Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Rhizoma Gastrodiae Tablets Manufacturers, Product Type & Application Table 31. Global Rhizoma Gastrodiae Tablets Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Rhizoma Gastrodiae Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Rhizoma Gastrodiae Tablets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Rhizoma Gastrodiae Tablets Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Rhizoma Gastrodiae Tablets Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Type (2021-2026) Table 38. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Type (2027-2032) Table 39. Global Rhizoma Gastrodiae Tablets Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Rhizoma Gastrodiae Tablets Sales by Type (2021-2026) & (k units) Table 41. Global Rhizoma Gastrodiae Tablets Sales by Type (2027-2032) & (k units) Table 42. Global Rhizoma Gastrodiae Tablets Sales Market Share by Type (2021-2026) Table 43. Global Rhizoma Gastrodiae Tablets Sales Market Share by Type (2027-2032) Table 44. Global Rhizoma Gastrodiae Tablets Price by Type (2021-2026) & (US$/unit) Table 45. Global Rhizoma Gastrodiae Tablets Price by Type (2027-2032) & (US$/unit) Table 46. Global Rhizoma Gastrodiae Tablets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Rhizoma Gastrodiae Tablets Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Rhizoma Gastrodiae Tablets Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Application (2021-2026) Table 50. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Application (2027-2032) Table 51. Global Rhizoma Gastrodiae Tablets Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Rhizoma Gastrodiae Tablets Sales by Application (2021-2026) & (k units) Table 53. Global Rhizoma Gastrodiae Tablets Sales by Application (2027-2032) & (k units) Table 54. Global Rhizoma Gastrodiae Tablets Sales Market Share by Application (2021-2026) Table 55. Global Rhizoma Gastrodiae Tablets Sales Market Share by Application (2027-2032) Table 56. Global Rhizoma Gastrodiae Tablets Price by Application (2021-2026) & (US$/unit) Table 57. Global Rhizoma Gastrodiae Tablets Price by Application (2027-2032) & (US$/unit) Table 58. Zhaotong Huacheng Pharmaceutical Company Information Table 59. Zhaotong Huacheng Pharmaceutical Business Overview Table 60. Zhaotong Huacheng Pharmaceutical Rhizoma Gastrodiae Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Zhaotong Huacheng Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio Table 62. Zhaotong Huacheng Pharmaceutical Recent Development Table 63. Taiji Group Sichuan Mianyang Pharmaceutical Company Information Table 64. Taiji Group Sichuan Mianyang Pharmaceutical Business Overview Table 65. Taiji Group Sichuan Mianyang Pharmaceutical Rhizoma Gastrodiae Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Taiji Group Sichuan Mianyang Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio Table 67. Taiji Group Sichuan Mianyang Pharmaceutical Recent Development Table 68. Shaanxi Tianyang Pharmaceutical Company Information Table 69. Shaanxi Tianyang Pharmaceutical Business Overview Table 70. Shaanxi Tianyang Pharmaceutical Rhizoma Gastrodiae Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Shaanxi Tianyang Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio Table 72. Shaanxi Tianyang Pharmaceutical Recent Development Table 73. Tsumura & Co. Company Information Table 74. Tsumura & Co. Business Overview Table 75. Tsumura & Co. Rhizoma Gastrodiae Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Tsumura & Co. Rhizoma Gastrodiae Tablets Product Portfolio Table 77. Tsumura & Co. Recent Development Table 78. Lanzhou Foci Pharmaceutical Company Information Table 79. Lanzhou Foci Pharmaceutical Business Overview Table 80. Lanzhou Foci Pharmaceutical Rhizoma Gastrodiae Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Lanzhou Foci Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio Table 82. Lanzhou Foci Pharmaceutical Recent Development Table 83. Guizhou Bailing Company Information Table 84. Guizhou Bailing Business Overview Table 85. Guizhou Bailing Rhizoma Gastrodiae Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Guizhou Bailing Rhizoma Gastrodiae Tablets Product Portfolio Table 87. Guizhou Bailing Recent Development Table 88. Guangxi Chanfang Pharmaceutical Company Information Table 89. Guangxi Chanfang Pharmaceutical Business Overview Table 90. Guangxi Chanfang Pharmaceutical Rhizoma Gastrodiae Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Guangxi Chanfang Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio Table 92. Guangxi Chanfang Pharmaceutical Recent Development Table 93. Guangdong Luofushan National Pharmaceutical Company Information Table 94. Guangdong Luofushan National Pharmaceutical Business Overview Table 95. Guangdong Luofushan National Pharmaceutical Rhizoma Gastrodiae Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Guangdong Luofushan National Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio Table 97. Guangdong Luofushan National Pharmaceutical Recent Development Table 98. Tongrentang Chinese Medicine Company Information Table 99. Tongrentang Chinese Medicine Business Overview Table 100. Tongrentang Chinese Medicine Rhizoma Gastrodiae Tablets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Tongrentang Chinese Medicine Rhizoma Gastrodiae Tablets Product Portfolio Table 102. Tongrentang Chinese Medicine Recent Development Table 103. North America Rhizoma Gastrodiae Tablets Revenue by Type (2021-2026) & (US$ Million) Table 104. North America Rhizoma Gastrodiae Tablets Revenue by Type (2027-2032) & (US$ Million) Table 105. North America Rhizoma Gastrodiae Tablets Sales by Type (2021-2026) & (k units) Table 106. North America Rhizoma Gastrodiae Tablets Sales by Type (2027-2032) & (k units) Table 107. North America Rhizoma Gastrodiae Tablets Sales Price by Type (2021-2026) & (US$/unit) Table 108. North America Rhizoma Gastrodiae Tablets Sales Price by Type (2027-2032) & (US$/unit) Table 109. North America Rhizoma Gastrodiae Tablets Revenue by Application (2021-2026) & (US$ Million) Table 110. North America Rhizoma Gastrodiae Tablets Revenue by Application (2027-2032) & (US$ Million) Table 111. North America Rhizoma Gastrodiae Tablets Sales by Application (2021-2026) & (k units) Table 112. North America Rhizoma Gastrodiae Tablets Sales by Application (2027-2032) & (k units) Table 113. North America Rhizoma Gastrodiae Tablets Sales Price by Application (2021-2026) & (US$/unit) Table 114. North America Rhizoma Gastrodiae Tablets Sales Price by Application (2027-2032) & (US$/unit) Table 115. North America Rhizoma Gastrodiae Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Rhizoma Gastrodiae Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 117. North America Rhizoma Gastrodiae Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 118. North America Rhizoma Gastrodiae Tablets Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 119. North America Rhizoma Gastrodiae Tablets Sales by Country (2021-2026) & (k units) Table 120. North America Rhizoma Gastrodiae Tablets Sales by Country (2027-2032) & (k units) Table 121. North America Rhizoma Gastrodiae Tablets Sales Price by Country (2021-2026) & (US$/unit) Table 122. North America Rhizoma Gastrodiae Tablets Sales Price by Country (2027-2032) & (US$/unit) Table 123. United States Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 124. Canada Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 125. Mexico Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 126. Europe Rhizoma Gastrodiae Tablets Revenue by Type (2021-2026) & (US$ Million) Table 127. Europe Rhizoma Gastrodiae Tablets Revenue by Type (2027-2032) & (US$ Million) Table 128. Europe Rhizoma Gastrodiae Tablets Sales by Type (2021-2026) & (k units) Table 129. Europe Rhizoma Gastrodiae Tablets Sales by Type (2027-2032) & (k units) Table 130. Europe Rhizoma Gastrodiae Tablets Sales Price by Type (2021-2026) & (US$/unit) Table 131. Europe Rhizoma Gastrodiae Tablets Sales Price by Type (2027-2032) & (US$/unit) Table 132. Europe Rhizoma Gastrodiae Tablets Revenue by Application (2021-2026) & (US$ Million) Table 133. Europe Rhizoma Gastrodiae Tablets Revenue by Application (2027-2032) & (US$ Million) Table 134. Europe Rhizoma Gastrodiae Tablets Sales by Application (2021-2026) & (k units) Table 135. Europe Rhizoma Gastrodiae Tablets Sales by Application (2027-2032) & (k units) Table 136. Europe Rhizoma Gastrodiae Tablets Sales Price by Application (2021-2026) & (US$/unit) Table 137. Europe Rhizoma Gastrodiae Tablets Sales Price by Application (2027-2032) & (US$/unit) Table 138. Europe Rhizoma Gastrodiae Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Rhizoma Gastrodiae Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Europe Rhizoma Gastrodiae Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Europe Rhizoma Gastrodiae Tablets Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 142. Europe Rhizoma Gastrodiae Tablets Sales by Country (2021-2026) & (k units) Table 143. Europe Rhizoma Gastrodiae Tablets Sales by Country (2027-2032) & (k units) Table 144. Europe Rhizoma Gastrodiae Tablets Sales Price by Country (2021-2026) & (US$/unit) Table 145. Europe Rhizoma Gastrodiae Tablets Sales Price by Country (2027-2032) & (US$/unit) Table 146. Germany Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 147. France Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 148. U.K. Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 149. Italy Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 150. Russia Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 151. Spain Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 152. Netherlands Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 153. Switzerland Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 154. Sweden Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 155. Poland Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 156. China Rhizoma Gastrodiae Tablets Revenue by Type (2021-2026) & (US$ Million) Table 157. China Rhizoma Gastrodiae Tablets Revenue by Type (2027-2032) & (US$ Million) Table 158. China Rhizoma Gastrodiae Tablets Sales by Type (2021-2026) & (k units) Table 159. China Rhizoma Gastrodiae Tablets Sales by Type (2027-2032) & (k units) Table 160. China Rhizoma Gastrodiae Tablets Sales Price by Type (2021-2026) & (US$/unit) Table 161. China Rhizoma Gastrodiae Tablets Sales Price by Type (2027-2032) & (US$/unit) Table 162. China Rhizoma Gastrodiae Tablets Revenue by Application (2021-2026) & (US$ Million) Table 163. China Rhizoma Gastrodiae Tablets Revenue by Application (2027-2032) & (US$ Million) Table 164. China Rhizoma Gastrodiae Tablets Sales by Application (2021-2026) & (k units) Table 165. China Rhizoma Gastrodiae Tablets Sales by Application (2027-2032) & (k units) Table 166. China Rhizoma Gastrodiae Tablets Sales Price by Application (2021-2026) & (US$/unit) Table 167. China Rhizoma Gastrodiae Tablets Sales Price by Application (2027-2032) & (US$/unit) Table 168. Asia Rhizoma Gastrodiae Tablets Revenue by Type (2021-2026) & (US$ Million) Table 169. Asia Rhizoma Gastrodiae Tablets Revenue by Type (2027-2032) & (US$ Million) Table 170. Asia Rhizoma Gastrodiae Tablets Sales by Type (2021-2026) & (k units) Table 171. Asia Rhizoma Gastrodiae Tablets Sales by Type (2027-2032) & (k units) Table 172. Asia Rhizoma Gastrodiae Tablets Sales Price by Type (2021-2026) & (US$/unit) Table 173. Asia Rhizoma Gastrodiae Tablets Sales Price by Type (2027-2032) & (US$/unit) Table 174. Asia Rhizoma Gastrodiae Tablets Revenue by Application (2021-2026) & (US$ Million) Table 175. Asia Rhizoma Gastrodiae Tablets Revenue by Application (2027-2032) & (US$ Million) Table 176. Asia Rhizoma Gastrodiae Tablets Sales by Application (2021-2026) & (k units) Table 177. Asia Rhizoma Gastrodiae Tablets Sales by Application (2027-2032) & (k units) Table 178. Asia Rhizoma Gastrodiae Tablets Sales Price by Application (2021-2026) & (US$/unit) Table 179. Asia Rhizoma Gastrodiae Tablets Sales Price by Application (2027-2032) & (US$/unit) Table 180. Asia Rhizoma Gastrodiae Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Asia Rhizoma Gastrodiae Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. Asia Rhizoma Gastrodiae Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. Asia Rhizoma Gastrodiae Tablets Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 184. Asia Rhizoma Gastrodiae Tablets Sales by Country (2021-2026) & (k units) Table 185. Asia Rhizoma Gastrodiae Tablets Sales by Country (2027-2032) & (k units) Table 186. Asia Rhizoma Gastrodiae Tablets Sales Price by Country (2021-2026) & (US$/unit) Table 187. Asia Rhizoma Gastrodiae Tablets Sales Price by Country (2027-2032) & (US$/unit) Table 188. Japan Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 189. South Korea Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 190. India Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 191. Australia Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 192. Taiwan Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 193. Southeast Asia Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 194. SAMEA Rhizoma Gastrodiae Tablets Revenue by Type (2021-2026) & (US$ Million) Table 195. SAMEA Rhizoma Gastrodiae Tablets Revenue by Type (2027-2032) & (US$ Million) Table 196. SAMEA Rhizoma Gastrodiae Tablets Sales by Type (2021-2026) & (k units) Table 197. SAMEA Rhizoma Gastrodiae Tablets Sales by Type (2027-2032) & (k units) Table 198. SAMEA Rhizoma Gastrodiae Tablets Sales Price by Type (2021-2026) & (US$/unit) Table 199. SAMEA Rhizoma Gastrodiae Tablets Sales Price by Type (2027-2032) & (US$/unit) Table 200. SAMEA Rhizoma Gastrodiae Tablets Revenue by Application (2021-2026) & (US$ Million) Table 201. SAMEA Rhizoma Gastrodiae Tablets Revenue by Application (2027-2032) & (US$ Million) Table 202. SAMEA Rhizoma Gastrodiae Tablets Sales by Application (2021-2026) & (k units) Table 203. SAMEA Rhizoma Gastrodiae Tablets Sales by Application (2027-2032) & (k units) Table 204. SAMEA Rhizoma Gastrodiae Tablets Sales Price by Application (2021-2026) & (US$/unit) Table 205. SAMEA Rhizoma Gastrodiae Tablets Sales Price by Application (2027-2032) & (US$/unit) Table 206. SAMEA Rhizoma Gastrodiae Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. SAMEA Rhizoma Gastrodiae Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. SAMEA Rhizoma Gastrodiae Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. SAMEA Rhizoma Gastrodiae Tablets Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 210. SAMEA Rhizoma Gastrodiae Tablets Sales by Country (2021-2026) & (k units) Table 211. SAMEA Rhizoma Gastrodiae Tablets Sales by Country (2027-2032) & (k units) Table 212. SAMEA Rhizoma Gastrodiae Tablets Sales Price by Country (2021-2026) & (US$/unit) Table 213. SAMEA Rhizoma Gastrodiae Tablets Sales Price by Country (2027-2032) & (US$/unit) Table 214. Brazil Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 215. Argentina Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 216. Chile Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 217. Colombia Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 218. Peru Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 219. Saudi Arabia Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 220. Israel Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 221. UAE Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 222. Turkey Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 223. Iran Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 224. Egypt Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Table 225. Key Raw Materials Table 226. Raw Materials Key Suppliers Table 227. Rhizoma Gastrodiae Tablets Distributors List Table 228. Rhizoma Gastrodiae Tablets Customers List Table 229. Research Programs/Design for This Report Table 230. Authors List of This Report Table 231. Secondary Sources Table 232. Primary Sources List of Figures Figure 1. Rhizoma Gastrodiae Tablets Image Figure 2. Global Rhizoma Gastrodiae Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rhizoma Gastrodiae Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 4. Gastrodia elata f.glauca Image Figure 5. G.elata.BI.f elata Image Figure 6. Other Image Figure 7. Global Rhizoma Gastrodiae Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Rhizoma Gastrodiae Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Pharmacies Image Figure 10. Online Pharmacies Image Figure 11. Retail Pharmacies Image Figure 12. Global Rhizoma Gastrodiae Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Rhizoma Gastrodiae Tablets Revenue (2021-2032) & (US$ Million) Figure 14. Global Rhizoma Gastrodiae Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Region (2021-2032) Figure 17. Global Rhizoma Gastrodiae Tablets Sales (2021-2032) & (k units) Figure 18. Global Rhizoma Gastrodiae Tablets Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Rhizoma Gastrodiae Tablets Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Rhizoma Gastrodiae Tablets Sales YoY (2021-2032) & (k units) Figure 21. Europe Rhizoma Gastrodiae Tablets Sales YoY (2021-2032) & (k units) Figure 22. China Rhizoma Gastrodiae Tablets Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Rhizoma Gastrodiae Tablets Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Rhizoma Gastrodiae Tablets Sales YoY (2021-2032) & (k units) Figure 25. Global Rhizoma Gastrodiae Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Rhizoma Gastrodiae Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Rhizoma Gastrodiae Tablets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Type (2021-2032) Figure 31. Global Rhizoma Gastrodiae Tablets Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Rhizoma Gastrodiae Tablets Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Rhizoma Gastrodiae Tablets Sales Market Share by Type (2021-2032) Figure 34. Global Rhizoma Gastrodiae Tablets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Rhizoma Gastrodiae Tablets Revenue Market Share by Application (2021-2032) Figure 37. Global Rhizoma Gastrodiae Tablets Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Rhizoma Gastrodiae Tablets Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Rhizoma Gastrodiae Tablets Sales Market Share by Application (2021-2032) Figure 40. North America Rhizoma Gastrodiae Tablets Revenue Share by Type (2021-2032) Figure 41. North America Rhizoma Gastrodiae Tablets Sales Share by Type (2021-2032) Figure 42. North America Rhizoma Gastrodiae Tablets Revenue Share by Application (2021-2032) Figure 43. North America Rhizoma Gastrodiae Tablets Sales Share by Application (2021-2032) Figure 44. North America Rhizoma Gastrodiae Tablets Revenue Share by Country (2021-2032) Figure 45. North America Rhizoma Gastrodiae Tablets Sales Share by Country (2021-2032) Figure 46. Europe Rhizoma Gastrodiae Tablets Revenue Share by Type (2021-2032) Figure 47. Europe Rhizoma Gastrodiae Tablets Sales Share by Type (2021-2032) Figure 48. Europe Rhizoma Gastrodiae Tablets Revenue Share by Application (2021-2032) Figure 49. Europe Rhizoma Gastrodiae Tablets Sales Share by Application (2021-2032) Figure 50. Europe Rhizoma Gastrodiae Tablets Revenue Share by Country (2021-2032) Figure 51. Europe Rhizoma Gastrodiae Tablets Sales Share by Country (2021-2032) Figure 52. China Rhizoma Gastrodiae Tablets Revenue Share by Type (2021-2032) Figure 53. China Rhizoma Gastrodiae Tablets Sales Share by Type (2021-2032) Figure 54. China Rhizoma Gastrodiae Tablets Revenue Share by Application (2021-2032) Figure 55. China Rhizoma Gastrodiae Tablets Sales Share by Application (2021-2032) Figure 56. Asia Rhizoma Gastrodiae Tablets Revenue Share by Type (2021-2032) Figure 57. Asia Rhizoma Gastrodiae Tablets Sales Share by Type (2021-2032) Figure 58. Asia Rhizoma Gastrodiae Tablets Revenue Share by Application (2021-2032) Figure 59. Asia Rhizoma Gastrodiae Tablets Sales Share by Application (2021-2032) Figure 60. Asia Rhizoma Gastrodiae Tablets Revenue Share by Country (2021-2032) Figure 61. Asia Rhizoma Gastrodiae Tablets Sales Share by Country (2021-2032) Figure 62. SAMEA Rhizoma Gastrodiae Tablets Revenue Share by Type (2021-2032) Figure 63. SAMEA Rhizoma Gastrodiae Tablets Sales Share by Type (2021-2032) Figure 64. SAMEA Rhizoma Gastrodiae Tablets Revenue Share by Application (2021-2032) Figure 65. SAMEA Rhizoma Gastrodiae Tablets Sales Share by Application (2021-2032) Figure 66. SAMEA Rhizoma Gastrodiae Tablets Revenue Share by Country (2021-2032) Figure 67. SAMEA Rhizoma Gastrodiae Tablets Sales Share by Country (2021-2032) Figure 68. Rhizoma Gastrodiae Tablets Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Rhizoma Gastrodiae Tablets Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Gastrodia elata f.glauca
  • G.elata.BI.f elata
  • Other
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Zhaotong Huacheng Pharmaceutical
  • Taiji Group Sichuan Mianyang Pharmaceutical
  • Shaanxi Tianyang Pharmaceutical
  • Tsumura & Co.
  • Lanzhou Foci Pharmaceutical
  • Guizhou Bailing
  • Guangxi Chanfang Pharmaceutical
  • Guangdong Luofushan National Pharmaceutical
  • Tongrentang Chinese Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Rhizoma Gastrodiae Tablets Market by Type
  3. 1.2.1 Global Rhizoma Gastrodiae Tablets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Gastrodia elata f.glauca
  5. 1.2.3 G.elata.BI.f elata
  6. 1.2.4 Other
  7. 1.3 Rhizoma Gastrodiae Tablets Market by Application
  8. 1.3.1 Global Rhizoma Gastrodiae Tablets Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital Pharmacies
  10. 1.3.3 Online Pharmacies
  11. 1.3.4 Retail Pharmacies
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Rhizoma Gastrodiae Tablets Market Dynamics
  1. 2.1 Rhizoma Gastrodiae Tablets Industry Trends
  2. 2.2 Rhizoma Gastrodiae Tablets Industry Drivers
  3. 2.3 Rhizoma Gastrodiae Tablets Industry Opportunities and Challenges
  4. 2.4 Rhizoma Gastrodiae Tablets Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Rhizoma Gastrodiae Tablets Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Rhizoma Gastrodiae Tablets Revenue by Region
  3. 3.2.1 Global Rhizoma Gastrodiae Tablets Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Rhizoma Gastrodiae Tablets Revenue by Region (2021-2026)
  5. 3.2.3 Global Rhizoma Gastrodiae Tablets Revenue by Region (2027-2032)
  6. 3.2.4 Global Rhizoma Gastrodiae Tablets Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Rhizoma Gastrodiae Tablets Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Rhizoma Gastrodiae Tablets Sales by Region
  9. 3.4.1 Global Rhizoma Gastrodiae Tablets Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Rhizoma Gastrodiae Tablets Sales by Region (2021-2026)
  11. 3.4.3 Global Rhizoma Gastrodiae Tablets Sales by Region (2027-2032)
  12. 3.4.4 Global Rhizoma Gastrodiae Tablets Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Rhizoma Gastrodiae Tablets Revenue by Manufacturers
  2. 4.1.1 Global Rhizoma Gastrodiae Tablets Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Rhizoma Gastrodiae Tablets Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Rhizoma Gastrodiae Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Rhizoma Gastrodiae Tablets Sales by Manufacturers
  6. 4.2.1 Global Rhizoma Gastrodiae Tablets Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Rhizoma Gastrodiae Tablets Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Rhizoma Gastrodiae Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Rhizoma Gastrodiae Tablets Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Rhizoma Gastrodiae Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Rhizoma Gastrodiae Tablets Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Rhizoma Gastrodiae Tablets Manufacturers, Product Type & Application
  13. 4.7 Global Rhizoma Gastrodiae Tablets Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Rhizoma Gastrodiae Tablets Market CR5 and HHI
  16. 4.8.2 2025 Rhizoma Gastrodiae Tablets Tier 1, Tier 2, and Tier 3
5 Rhizoma Gastrodiae Tablets Market by Type
  1. 5.1 Global Rhizoma Gastrodiae Tablets Revenue by Type
  2. 5.1.1 Global Rhizoma Gastrodiae Tablets Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Rhizoma Gastrodiae Tablets Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Rhizoma Gastrodiae Tablets Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Rhizoma Gastrodiae Tablets Sales by Type
  6. 5.2.1 Global Rhizoma Gastrodiae Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rhizoma Gastrodiae Tablets Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Rhizoma Gastrodiae Tablets Sales Market Share by Type (2021-2032)
  9. 5.3 Global Rhizoma Gastrodiae Tablets Price by Type
6 Rhizoma Gastrodiae Tablets Market by Application
  1. 6.1 Global Rhizoma Gastrodiae Tablets Revenue by Application
  2. 6.1.1 Global Rhizoma Gastrodiae Tablets Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Rhizoma Gastrodiae Tablets Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Rhizoma Gastrodiae Tablets Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Rhizoma Gastrodiae Tablets Sales by Application
  6. 6.2.1 Global Rhizoma Gastrodiae Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Rhizoma Gastrodiae Tablets Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Rhizoma Gastrodiae Tablets Sales Market Share by Application (2021-2032)
  9. 6.3 Global Rhizoma Gastrodiae Tablets Price by Application
7 Company Profiles
  1. 7.1 Zhaotong Huacheng Pharmaceutical
  2. 7.1.1 Zhaotong Huacheng Pharmaceutical Company Information
  3. 7.1.2 Zhaotong Huacheng Pharmaceutical Business Overview
  4. 7.1.3 Zhaotong Huacheng Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zhaotong Huacheng Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
  6. 7.1.5 Zhaotong Huacheng Pharmaceutical Recent Developments
  7. 7.2 Taiji Group Sichuan Mianyang Pharmaceutical
  8. 7.2.1 Taiji Group Sichuan Mianyang Pharmaceutical Company Information
  9. 7.2.2 Taiji Group Sichuan Mianyang Pharmaceutical Business Overview
  10. 7.2.3 Taiji Group Sichuan Mianyang Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Taiji Group Sichuan Mianyang Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
  12. 7.2.5 Taiji Group Sichuan Mianyang Pharmaceutical Recent Developments
  13. 7.3 Shaanxi Tianyang Pharmaceutical
  14. 7.3.1 Shaanxi Tianyang Pharmaceutical Company Information
  15. 7.3.2 Shaanxi Tianyang Pharmaceutical Business Overview
  16. 7.3.3 Shaanxi Tianyang Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Shaanxi Tianyang Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
  18. 7.3.5 Shaanxi Tianyang Pharmaceutical Recent Developments
  19. 7.4 Tsumura & Co.
  20. 7.4.1 Tsumura & Co. Company Information
  21. 7.4.2 Tsumura & Co. Business Overview
  22. 7.4.3 Tsumura & Co. Rhizoma Gastrodiae Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Tsumura & Co. Rhizoma Gastrodiae Tablets Product Portfolio
  24. 7.4.5 Tsumura & Co. Recent Developments
  25. 7.5 Lanzhou Foci Pharmaceutical
  26. 7.5.1 Lanzhou Foci Pharmaceutical Company Information
  27. 7.5.2 Lanzhou Foci Pharmaceutical Business Overview
  28. 7.5.3 Lanzhou Foci Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Lanzhou Foci Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
  30. 7.5.5 Lanzhou Foci Pharmaceutical Recent Developments
  31. 7.6 Guizhou Bailing
  32. 7.6.1 Guizhou Bailing Company Information
  33. 7.6.2 Guizhou Bailing Business Overview
  34. 7.6.3 Guizhou Bailing Rhizoma Gastrodiae Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Guizhou Bailing Rhizoma Gastrodiae Tablets Product Portfolio
  36. 7.6.5 Guizhou Bailing Recent Developments
  37. 7.7 Guangxi Chanfang Pharmaceutical
  38. 7.7.1 Guangxi Chanfang Pharmaceutical Company Information
  39. 7.7.2 Guangxi Chanfang Pharmaceutical Business Overview
  40. 7.7.3 Guangxi Chanfang Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Guangxi Chanfang Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
  42. 7.7.5 Guangxi Chanfang Pharmaceutical Recent Developments
  43. 7.8 Guangdong Luofushan National Pharmaceutical
  44. 7.8.1 Guangdong Luofushan National Pharmaceutical Company Information
  45. 7.8.2 Guangdong Luofushan National Pharmaceutical Business Overview
  46. 7.8.3 Guangdong Luofushan National Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Guangdong Luofushan National Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
  48. 7.8.5 Guangdong Luofushan National Pharmaceutical Recent Developments
  49. 7.9 Tongrentang Chinese Medicine
  50. 7.9.1 Tongrentang Chinese Medicine Company Information
  51. 7.9.2 Tongrentang Chinese Medicine Business Overview
  52. 7.9.3 Tongrentang Chinese Medicine Rhizoma Gastrodiae Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Tongrentang Chinese Medicine Rhizoma Gastrodiae Tablets Product Portfolio
  54. 7.9.5 Tongrentang Chinese Medicine Recent Developments
8 North America
  1. 8.1 North America Rhizoma Gastrodiae Tablets Market Size by Type
  2. 8.1.1 North America Rhizoma Gastrodiae Tablets Revenue by Type (2021-2032)
  3. 8.1.2 North America Rhizoma Gastrodiae Tablets Sales by Type (2021-2032)
  4. 8.1.3 North America Rhizoma Gastrodiae Tablets Price by Type (2021-2032)
  5. 8.2 North America Rhizoma Gastrodiae Tablets Market Size by Application
  6. 8.2.1 North America Rhizoma Gastrodiae Tablets Revenue by Application (2021-2032)
  7. 8.2.2 North America Rhizoma Gastrodiae Tablets Sales by Application (2021-2032)
  8. 8.2.3 North America Rhizoma Gastrodiae Tablets Price by Application (2021-2032)
  9. 8.3 North America Rhizoma Gastrodiae Tablets Market Size by Country
  10. 8.3.1 North America Rhizoma Gastrodiae Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Rhizoma Gastrodiae Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Rhizoma Gastrodiae Tablets Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Rhizoma Gastrodiae Tablets Market Size by Type
  2. 9.1.1 Europe Rhizoma Gastrodiae Tablets Revenue by Type (2021-2032)
  3. 9.1.2 Europe Rhizoma Gastrodiae Tablets Sales by Type (2021-2032)
  4. 9.1.3 Europe Rhizoma Gastrodiae Tablets Price by Type (2021-2032)
  5. 9.2 Europe Rhizoma Gastrodiae Tablets Market Size by Application
  6. 9.2.1 Europe Rhizoma Gastrodiae Tablets Revenue by Application (2021-2032)
  7. 9.2.2 Europe Rhizoma Gastrodiae Tablets Sales by Application (2021-2032)
  8. 9.2.3 Europe Rhizoma Gastrodiae Tablets Price by Application (2021-2032)
  9. 9.3 Europe Rhizoma Gastrodiae Tablets Market Size by Country
  10. 9.3.1 Europe Rhizoma Gastrodiae Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Rhizoma Gastrodiae Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Rhizoma Gastrodiae Tablets Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Rhizoma Gastrodiae Tablets Market Size by Type
  2. 10.1.1 China Rhizoma Gastrodiae Tablets Revenue by Type (2021-2032)
  3. 10.1.2 China Rhizoma Gastrodiae Tablets Sales by Type (2021-2032)
  4. 10.1.3 China Rhizoma Gastrodiae Tablets Price by Type (2021-2032)
  5. 10.2 China Rhizoma Gastrodiae Tablets Market Size by Application
  6. 10.2.1 China Rhizoma Gastrodiae Tablets Revenue by Application (2021-2032)
  7. 10.2.2 China Rhizoma Gastrodiae Tablets Sales by Application (2021-2032)
  8. 10.2.3 China Rhizoma Gastrodiae Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Rhizoma Gastrodiae Tablets Market Size by Type
  2. 11.1.1 Asia Rhizoma Gastrodiae Tablets Revenue by Type (2021-2032)
  3. 11.1.2 Asia Rhizoma Gastrodiae Tablets Sales by Type (2021-2032)
  4. 11.1.3 Asia Rhizoma Gastrodiae Tablets Price by Type (2021-2032)
  5. 11.2 Asia Rhizoma Gastrodiae Tablets Market Size by Application
  6. 11.2.1 Asia Rhizoma Gastrodiae Tablets Revenue by Application (2021-2032)
  7. 11.2.2 Asia Rhizoma Gastrodiae Tablets Sales by Application (2021-2032)
  8. 11.2.3 Asia Rhizoma Gastrodiae Tablets Price by Application (2021-2032)
  9. 11.3 Asia Rhizoma Gastrodiae Tablets Market Size by Country
  10. 11.3.1 Asia Rhizoma Gastrodiae Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Rhizoma Gastrodiae Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Rhizoma Gastrodiae Tablets Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Rhizoma Gastrodiae Tablets Market Size by Type
  2. 12.1.1 SAMEA Rhizoma Gastrodiae Tablets Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Rhizoma Gastrodiae Tablets Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Rhizoma Gastrodiae Tablets Price by Type (2021-2032)
  5. 12.2 SAMEA Rhizoma Gastrodiae Tablets Market Size by Application
  6. 12.2.1 SAMEA Rhizoma Gastrodiae Tablets Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Rhizoma Gastrodiae Tablets Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Rhizoma Gastrodiae Tablets Price by Application (2021-2032)
  9. 12.3 SAMEA Rhizoma Gastrodiae Tablets Market Size by Country
  10. 12.3.1 SAMEA Rhizoma Gastrodiae Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Rhizoma Gastrodiae Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Rhizoma Gastrodiae Tablets Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Rhizoma Gastrodiae Tablets Value Chain Analysis
  2. 13.1.1 Rhizoma Gastrodiae Tablets Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Rhizoma Gastrodiae Tablets Production Mode & Process
  6. 13.2 Rhizoma Gastrodiae Tablets Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Rhizoma Gastrodiae Tablets Distributors
  9. 13.2.3 Rhizoma Gastrodiae Tablets Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research